Hans Christian Andersen Children's Hospital
Odense, 5000, Denmark
Location status: Recruiting
NCT Number: NCT06455800
Only little information exists about the long term consequences of having severe lung disease in childhood. The patient population is heterogenous and the prognostic markers are few.
This observational study will investigate which parameters that can be used to predict the outcome of having severe lung disease in childhood.
Interested in participating?
Request Info1 day–18 year
All sexes
Observational
Odense, 5000, Denmark
Location status: Recruiting
All patients aged 0-18 years at the HCA Childrens Hospital with a severe lung disease will prospectively be registered in a database.
At a yearly follow up, data from the patient record will be registered. Informed consent from the patients and/or their parents will be obtained. Registered data will include height, weight, results of lung function tests and imaging diagnostics.
The study will provide knowledge of the prognosis of different lung diseases and how to monitor lung function in children.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
severe lung disease -
Exclusion criteria
no informed consent
-
Patients will once a year be monitored with different lung function methods
Time frame: 18 years
liter
Time frame: 18 years
liter
Time frame: 18 years
number
Time frame: 18 years
meters
Contact information is provided by the study sponsor or research team.
Odense University Hospital
Other
Long Term Outcome of Severe Lung Disease in Childhood
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06385301
Lung Disease Chronic, Lung Diseases
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT05835271
Lung Disease Chronic
Toronto, Ontario, Canada
View Trial DetailsNCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial DetailsNCT03746392
Brain Diseases, Cardiovascular Diseases
Seattle, Washington, United States
View Trial Details